Acción 1548 GENSCRIPT BIOTECH CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Genscript Biotech Corporation

Acciones

1548

KYG3825B1059

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:08:20 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
11,02 HKD +2,42 % Gráfico intradía de Genscript Biotech Corporation +5,56 % -44,51 %
23/04 Multiply Labs y GenScript Biotech Corporation colaboran para automatizar la fase de aislamiento y enriquecimiento celular de la fabricación de terapias celulares CI
12/04 Genscript Biotech Corporation anuncia los nombramientos de sus directores y el cambio en la composición del comité del consejo de administración CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
GenScript Biotech Releases 2023 ESG Report, Deepening Green Development Practices, Constructing Sustainable Future Blueprint
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission
Genscript Biotech's Unit Logs $157 Million in Q1 Sales of Blood Cancer Drug
GenScript Biotech officially joins SBTi to fulfill its sustainability commitment
Genscript Biotech Corporation Announces Directorate Appointments and Change in Composition of Board Committee
Genscript Biotech Unit's Refractory Multiple Myeloma Drug Gets FDA Approval
GenScript Biotech Receives EcoVadis Bronze Medal for Outstanding Sustainability Performance
Genscript Biotech's US Unit Secures FDA Nod for Anti-Cancer Medication
Genscript Biotech Issues 444,598 Shares to Three Grantees Under Restricted Share Scheme
Genscript Biotech's 2023 Loss Widens; Misses Revenue Estimates
Genscript Biotech Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Genscript Announces Appointment of Dr. David R. Liu to the Scientific Advisory Board
Immunotherapy Pioneer Carl H. June, MD, Joins GenScript's Scientific Advisory Board to Guide Company's Innovation Strategy in Advancing Cell and Gene Therapy Breakthroughs
GenScript Biotech Corporation Expands Collaboration with Roche
GenScript Announces Its Inaugural Life Science Research Grant Project
Genscript Biotech Unit Rakes in $159 Million in Sales for Myeloma Treatment; Shares Rise 4%
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 1548
  4. Noticias Genscript Biotech Corporation
  5. Otros idiomas